Research Peptide
Tesamorelin
TBC
FDA-approved as Egrifta (Theratechnologies) for HIV-associated lipodystrophy. Studied in GH axis research, visceral adiposity, and cognitive function models.
For research reference only. Not a clinical recommendation.